In vitro effects of taxol on ciliogenesis in quail oviduct

When induced by in vivo oestrogen stimulation, ciliogenesis continues in culture in vitro of quail oviduct implants. Ultrastructure of ciliogenic cells was compared after culture for 24 or 48 h in the presence or absence of 10(−5) M-taxol. Taxol, which promotes polymerization and stabilization of microtubules, disturbed ciliogenesis, but formation of basal bodies was unaffected by the drug. Conversely, their migration towards the apical surface seemed to be slowed down or blocked and axonemal doublets polymerized onto the distal end of cytoplasmic basal bodies. They elongated and often constituted a more or less complete axoneme, extending between organelles in various orientations. These axonemes, often abnormal, were not surrounded by a membrane, with the exception of the transitional or neck region between the basal body and axoneme. The formation of membrane in this area resulted from the binding of some vesicles to the anchoring fibres of the basal body. They fused in various numbers, occasionally forming a ring, at the site of the transitional region, and exhibited the characteristics of the ciliary necklace. The association of basal bodies with vesicles or with the plasma membrane appeared to be a necessary signal for in situ polymerization of axonemal doublets. In addition, taxol induced polymerization of numerous microtubules in the cytoplasm, especially in the apical part of the cell and in the Golgi area. This network of microtubules may prevent basal body migration.

Download Full-text

Anti-obesity role of Aster glehni extract: in vivo and in vitro effects

Planta Medica ◽

10.1055/s-0032-1320443 ◽

2012 ◽

Vol 78 (11) ◽

Author(s):

HM Lee ◽

TG Ahn ◽

CW Kim ◽

HJ An

Keyword(s):

In Vitro Effects

Download Full-text

Comparison of Specific Antibody, D-Phe-Pro-Arg-CH2Cl and Aprotinin for Prevention of In Vitro Effects of Recombinant Tissue-Type Plasminogen Activator on Haemostasis Parameters

Thrombosis and Haemostasis ◽

10.1055/s-0038-1646016 ◽

1987 ◽

Vol 58 (03) ◽

pp. 921-926 ◽

Cited By ~ 21

Author(s):

E Seifried ◽

P Tanswell

Keyword(s):

Specific Antibody ◽

Plasma Concentrations ◽

Fibrinolytic Therapy ◽

Tissue Type ◽

Control Value ◽

Type Plasminogen Activator ◽

In Vitro Effects ◽

Fibrinolytic Parameters

SummaryIn vitro, concentration-dependent effects of rt-PA on a range of coagulation and fibrinolytic assays in thawed plasma samples were investigated. In absence of a fibrinolytic inhibitor, 2 μg rt-PA/ml blood (3.4 μg/ml plasma) caused prolongation of clotting time assays and decreases of plasminogen (to 44% of the control value), fibrinogen (to 27%), α2-antiplasmin (to 5%), FV (to 67%), FVIII (to 41%) and FXIII (to 16%).Of three inhibitors tested, a specific polyclonal anti-rt-PA antibody prevented interferences in all fibrinolytic and most clotting assays. D-Phe-Pro-Arg-CH2Cl (PPACK) enabled correct assays of fibrinogen and fibrinolytic parameters but interfered with coagulometric assays dependent on endogenous thrombin generation. Aprotinin was suitable only for a restricted range of both assay types.Most in vitro effects were observed only with rt-PA plasma concentrations in excess of therapeutic values. Nevertheless it is concluded that for clinical application, collection of blood samples on either specific antibody or PPACK is essential for a correct assessment of in vivo effects of rt-PA on the haemostatic system in patients undergoing fibrinolytic therapy.

Download Full-text

In Vitro Effects of Sulforaphane on Interferon-Driven Inflammation and Exploratory Evaluation in Two Healthy Volunteers

Molecules ◽

10.3390/molecules26123602 ◽

2021 ◽

Vol 26 (12) ◽

pp. 3602

Author(s):

Elena Genova ◽

Maura Apollonio ◽

Giuliana Decorti ◽

Alessandra Tesser ◽

Alberto Tommasini ◽

...

Keyword(s):

Healthy Volunteers ◽

Supportive Therapy ◽

P Value ◽

Type I ◽

Interferon Signature ◽

Interferon Stimulated Genes ◽

Immune System Activation ◽

In Vitro Effects

Interferonopathies are rare genetic conditions defined by systemic inflammatory episodes caused by innate immune system activation in the absence of pathogens. Currently, no targeted drugs are authorized for clinical use in these diseases. In this work, we studied the contribution of sulforaphane (SFN), a cruciferous-derived bioactive molecule, in the modulation of interferon-driven inflammation in an immortalized human hepatocytes (IHH) line and in two healthy volunteers, focusing on STING, a key-component player in interferon pathway, interferon signature modulation, and GSTM1 expression and genotype, which contributes to SFN metabolism and excretion. In vitro, SFN exposure reduced STING expression as well as interferon signature in the presence of the pro-inflammatory stimulus cGAMP (cGAMP 3 h vs. SFN+cGAMP 3 h p value < 0.0001; cGAMP 6 h vs. SFN+cGAMP 6 h p < 0.001, one way ANOVA), restoring STING expression to the level of unstimulated cells. In preliminary experiments on healthy volunteers, no appreciable variations in interferon signature were identified after SFN assumption, while only in one of them, presenting the GSTM1 wild type genotype related to reduced SFN excretion, could a downregulation of STING be recorded. This study confirmed that SFN inhibits STING-mediated inflammation and interferon-stimulated genes expression in vitro. However, only a trend towards the downregulation of STING could be reproduced in vivo. Results obtained have to be confirmed in a larger group of healthy individuals and in patients with type I interferonopathies to define if the assumption of SFN could be useful as supportive therapy.

Download Full-text

Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo

Scientific Reports ◽

10.1038/s41598-021-84817-2 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Katharina Ernst ◽

Ann-Katrin Mittler ◽

Veronika Winkelmann ◽

Carolin Kling ◽

Nina Eberhardt ◽

...

Keyword(s):

Pertussis Toxin ◽

Airway Epithelium ◽

Whooping Cough ◽

Apical Surface ◽

Basal Cells ◽

Pharmacological Chaperone ◽

Infant Mouse ◽

Novel Therapeutic Strategies

AbstractWhooping cough is caused by Bordetella pertussis that releases pertussis toxin (PT) which comprises enzyme A-subunit PTS1 and binding/transport B-subunit. After receptor-mediated endocytosis, PT reaches the endoplasmic reticulum from where unfolded PTS1 is transported to the cytosol. PTS1 ADP-ribosylates G-protein α-subunits resulting in increased cAMP signaling. Here, a role of target cell chaperones Hsp90, Hsp70, cyclophilins and FK506-binding proteins for cytosolic PTS1-uptake is demonstrated. PTS1 specifically and directly interacts with chaperones in vitro and in cells. Specific pharmacological chaperone inhibition protects CHO-K1, human primary airway basal cells and a fully differentiated airway epithelium from PT-intoxication by reducing intracellular PTS1-amounts without affecting cell binding or enzyme activity. PT is internalized by human airway epithelium secretory but not ciliated cells and leads to increase of apical surface liquid. Cyclophilin-inhibitors reduced leukocytosis in infant mouse model of pertussis, indicating their promising potential for developing novel therapeutic strategies against whooping cough.

Download Full-text

A Detailed Examination of the in vivo and in vitro Effects of ACTH on Gonadotropin Secretion in the Adult Rat

Neuroendocrinology ◽

10.1159/000124090 ◽

1985 ◽

Vol 40 (4) ◽

pp. 297-302 ◽

Cited By ~ 18

Author(s):

David R. Mann ◽

Diane Evans ◽

Festus Edoimioya ◽

Freja Kamel ◽

George M. Butterstein

Keyword(s):

Detailed Examination ◽

Gonadotropin Secretion ◽

Adult Rat ◽

In Vitro Effects

Download Full-text

Contamination of erythropoietin by endotoxin: in vivo and in vitro effects on murine erythropoiesis

Blood ◽

10.1182/blood.v54.1.146.146 ◽

1979 ◽

Vol 54 (1) ◽

pp. 146-158 ◽

Cited By ~ 8

Author(s):

KS Zuckerman ◽

PJ Quesenberry ◽

J Levin ◽

R Sullivan

Keyword(s):

Significant Inhibition ◽

Erythropoietic Activity ◽

Limulus Amebocyte Lysate ◽

Endogenous Erythropoietin ◽

Significant Change ◽

In Vitro Effects ◽

Stimulation Of

Abstract Endotoxin was detected in all erythropoietin preparations tested and was removed from four lots, without loss of erythropoietic activity, by adsorption with limulus amebocyte lysate. Comparison of adsorbed (endotoxin-depleted) and nonadsorbed (endotoxin-containing) erythropoietin preparations demonstrated significant inhibition of CFU- e and BFU-e in vitro by nonadsorbed erythropoietin at concentrations higher than 0.25 U/ml and 2.0 U/ml, respectively. CFU-e and BFU-e were inhibited significantly by readdition in vitro of 10(-5)-10(-3) mug of endotoxin per unit of limulus-adsorbed erythropoietin. Administration of saline or 6 U of nonadsorbed or adsorbed erythropoietin twice a day for 4 days of CF1 mice resulted in reticulocyte counts of 2.1%, 9.9%, and 15.9%, respectively. Nonadsorbed erythropoietin resulted in a 29% decrease in erythropoiesis, a 42% decrease in CFU-e, and a 16% increase in granulopoiesis in the marrow, whereas adsorbed erythropoietin caused a 28% increase in erythropoiesis, no significant change in CFU-e and a 19% decrease in granulopoiesis in the marrow. Both preparations resulted in marked increases in splenic erythropoiesis and granulopoiesis. The effects of adsorbed erythropoietin are similar to those produced following stimulation of hematopoiesis by endogenous erythropoietin. Hemopoietic changes induced by nonadsorbed erythropoietin in vivo and in vitro are affected substantially by contamination of the erythropoietin preparations with endotoxin.

Download Full-text